Certified by Founder Lodge
The Invus Group
United States - New York, NY
INVESTOR
1 Disclosed Funding Rounds $112,000,000
8 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Evergreen structure with over $8 billion under management. Offices in New York, Paris, and Hong Kong.
Company | Date | Round | Raised |
---|---|---|---|
Neumora | October, 17 ,2022 | Series B | $112,000,000 |
Hemab Therapeutics | February, 22 ,2023 | Series B | $135,000,000 |
Bicara Therapeutics | March, 07 ,2023 | Series B | $108,000,000 |
Ring Therapeutics | March, 10 ,2023 | Series C | $86,500,000 |
Convergent Therapeutics, Inc. | May, 04 ,2023 | Series A | $90,000,000 |
ElevateBio | May, 25 ,2023 | Series D | $401,000,000 |
Triveni Bio | October, 27 ,2023 | Series A | $92,000,000 |
Engine Biosciences | November, 01 ,2023 | Series A | $27,000,000 |